HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis.

Abstract
Intracellular pattern recognition receptors such as the nucleotide-binding oligomerization domain (NOD)-like receptors family members are key for innate immune recognition of microbial infection and may play important roles in the development of inflammatory diseases, including rheumatic diseases. In this study, we evaluated the role of NOD1 and NOD2 on development of experimental arthritis. Ag-induced arthritis was generated in wild-type, NOD1(-/-), NOD2(-/-), or receptor-interacting serine-threonine kinase 2(-/-) (RIPK2(-/-)) immunized mice challenged intra-articularly with methylated BSA. Nociception was determined by electronic Von Frey test. Neutrophil recruitment and histopathological analysis of proteoglycan lost was evaluated in inflamed joints. Joint levels of inflammatory cytokine/chemokine were measured by ELISA. Cytokine (IL-6 and IL-23) and NOD2 expressions were determined in mice synovial tissue by RT-PCR. The NOD2(-/-) and RIPK2(-/-), but not NOD1(-/-), mice are protected from Ag-induced arthritis, which was characterized by a reduction in neutrophil recruitment, nociception, and cartilage degradation. NOD2/RIPK2 signaling impairment was associated with a reduction in proinflammatory cytokines and chemokines (TNF, IL-1β, and CXCL1/KC). IL-17 and IL-17 triggering cytokines (IL-6 and IL-23) were also reduced in the joint, but there is no difference in the percentage of CD4(+) IL-17(+) cells in the lymph node between arthritic wild-type and NOD2(-/-) mice. Altogether, these findings point to a pivotal role of the NOD2/RIPK2 signaling in the onset of experimental arthritis by triggering an IL-17-dependent joint immune response. Therefore, we could propose that NOD2 signaling is a target for the development of new therapies for the control of rheumatoid arthritis.
AuthorsSilvio M Vieira, Thiago M Cunha, Rafael F O França, Larissa G Pinto, Jhimmy Talbot, Walter M Turato, Henrique P Lemos, Jonilson B Lima, Waldiceu A Verri Jr, Sérgio C L Almeida, Sergio H Ferreira, Paulo Louzada-Junior, Dario S Zamboni, Fernando Q Cunha
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 188 Issue 10 Pg. 5116-22 (May 15 2012) ISSN: 1550-6606 [Electronic] United States
PMID22491249 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Il17a protein, mouse
  • Interleukin-17
  • Nod1 Signaling Adaptor Protein
  • Nod1 protein, mouse
  • Nod2 Signaling Adaptor Protein
  • Nod2 protein, mouse
  • methylated bovine serum albumin
  • Serum Albumin, Bovine
  • Receptor-Interacting Protein Serine-Threonine Kinase 2
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • Ripk2 protein, mouse
Topics
  • Animals
  • Arthritis, Experimental (immunology, metabolism, pathology)
  • Cattle
  • Cells, Cultured
  • Interleukin-17 (metabolism, physiology)
  • Knee Joint (immunology, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nod1 Signaling Adaptor Protein (deficiency)
  • Nod2 Signaling Adaptor Protein (deficiency, physiology)
  • Receptor-Interacting Protein Serine-Threonine Kinase 2
  • Receptor-Interacting Protein Serine-Threonine Kinases (deficiency, physiology)
  • Serum Albumin, Bovine (immunology, toxicity)
  • Signal Transduction (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: